11 – 20 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Engineered human mesenchymal stem cells for neuroblastoma therapeutics
(
- Contribution to journal › Article
-
Mark
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
(
- Contribution to journal › Article
-
Mark
ALK positively regulates MYCN activity through repression of HBP1 expression
(
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
Patient-derived xenografts as preclinical neuroblastoma models
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
- 2016
-
Mark
Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
(
- Contribution to journal › Article